Improving the managed entry of new medicines: sharing experiences across Europe

被引：0

作者：

Godman, Brian ^{[1
,2
,3
]}

Paterson, Ken ^{[4
]}

Malmstrom, Rickard E. ^{[5
]}

Selke, Gisbert ^{[6
]}

Fagot, Jean-Paul ^{[7
]}

Mrak, Jana ^{[8
]}

机构：

[1] Karolinska Univ, Huddinge Hosp, Div Clin Pharmacol, Stockholm, Sweden

[2] Mario Negri Inst Pharmacol Res, Milan, Italy

[3] Univ Liverpool, Prescribing Res Grp, Sch Management, Liverpool L69 3BX, Merseyside, England

[4] Scottish Med Consortium, Glasgow, Lanark, Scotland

[5] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Med,Div Clin Pharmacol, Stockholm, Sweden

[6] AOK WidO, Wissensch Inst, Berlin, Germany

[7] Caisse Natl Assurance Maladie Travailleurs Salari, DSES, DEPP, Paris, France

[8] Hlth Insurance Inst Slovenia, Ljubljana, Slovenia

来源：

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH | 2012年 / 12卷 / 04期

关键词：

demand-side measures; horizon scanning; HTA; indicators; managed entry; pharmaceuticals; RECOMMENDATIONS; CARE; RISK;

D O I：

10.1586/ERP.12.44

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

The Managed Introduction of New Medicines Ljubljana, Slovenia, 19-21 March 2012 The 3-day course on the managed entry of new medicines was run by the Piperska group, which is a pan-European group striving to enhance the health of the public as a whole and the individual patient through exchanging ideas and research around the rational use of drugs. Participants included health authority and health insurance personnel, academics and those from commercial organizations. The principal aim of the conference was to bring together people to discuss ways to improve the managed entry of new drugs.

引用

页码：439 / 441

页数：3

共 50 条

[31] Children as Decision Makers in Education: Sharing Experiences across Cultures
Sherman, Ann
BRITISH JOURNAL OF EDUCATIONAL STUDIES, 2011, 59 (01) : 98 - 99
[32] Secure data sharing across portals: experiences from OneVRE
Turner, Martin
Jones, Michael
Poschen, Meik
Procter, Rob
Rowley, Andrew
Schiebeck, Tobias
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES, 2013, 371 (1983):
[33] AVENUES FOR SHARING LEARNING, SOLIDARITY AND LIFE EXPERIENCES ACROSS GENERATIONS
Ivan, Dragos Lucian
QUALITY AND EFFICIENCY IN E-LEARNING, VOL 1, 2013, : 628 - 633
[34] EXPLORING PATIENTS' EXPERIENCES OF THE NEW MEDICINES SERVICE (NMS)
Salema, N.
Latif, A.
Watmough, D.
Elliott, R. A.
Boyd, M. J.
Barber, N.
Chuter, A.
Davies, J.
Craig, C.
Waring, J.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (07) : O12 - O13
[35] CRITICAL DRUG EVALUATION TO OPTIMISE THE MANAGED ENTRY OF NEW DRUGS
Malmstrom, R. E.
Gustafsson, L. L.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 50 - 50
[36] The value of the managed entry of new drugs - A case study of donepezil
Payne, K
Davies, LM
Noyce, PR
Weiss, MC
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2003, 19 (01) : 114 - 128
[37] Market Access to New Medicines for Children with Cancer in Europe
Schoot, R.
Otth, M.
Frederix, G.
Leufkens, B.
Vassal, G.
PEDIATRIC BLOOD & CANCER, 2021, 68 : S320 - S321
[38] Authorisation of new medicines for children with rheumatic diseases in Europe
Vesely, Richard
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 368 - 368
[39] New regulatory strategies to manage medicines shortages in Europe
Musazzi, Umberto M.
Di Giorgio, Domenico
Minghetti, Paola
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 579
[40] Managing new premium-priced medicines in Europe
Govin Permanand
Hanne Bak Pedersen
Journal of Pharmaceutical Policy and Practice, 8 (Suppl 1)

← 1 2 3 4 5 →